Document is current
Any future updates will be listed below
-
Authors
Capovilla, Giovanni
Pierobon, Elisa Sefora
Moletta, Lucia
Scarton, Alessia
Sciuto, Maria Elisa
Tagkalos, Evangelos
Uzun, Eren
De Pasqual, Carlo Alberto
Turolo, Cecilia
Zanchettin, Gianpietro
Riccio, Federica
Provenzano, Luca
Salvador, Renato
Berlth, Felix
Weindelmayer, Jacopo
Lonardi, Sara
Galuppo, Sara
Giacopuzzi, Simone
De Manzoni, Giovanni
Grimminger, Peter
Valmasoni, Michele
- License Information
-
More Information
Article History
First Online: 8 June 2025
Disclosure
: Sara Lonardi has received research funding (to Institution) from Amgen, Astellas, Astra Zeneca, Bayer, Bristol-Myers Squibb, Daichii Sankyo, Hutchinson, Incyte, Merck Serono, Mirati, MSD, Pfizer, Roche, and Servier; has received personal honoraria as invited speaker from Amgen, Astra Zeneca, Bristol-Myers Squibb, Incyte, GSK, Lilly, Merck Serono, MSD, Pierre-Fabre, Roche, Servier; and has participated in advisory boards for Amgen, Astellas, Astra Zeneca, Bayer, Bristol-Myers Squibb, Daiichi-Sankyo, GSK, Incyte, Lilly, Merck Serono, MSD, Servier, Takeda, Rottapharm, Beigene, Fosum, and Nimbus Therapeutics. Peter Grimminger is the proctor for Intuitive Surgical and an advisor for Medicaroid Europe, Medtronic, Richard Wolf, and JnJ.
